Cargando…
VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation
OBJECTIVES: In glaucomatous eyes, the main aqueous humor (AH) outflow pathway is damaged by accumulated oxidative stress arising from the microenvironment, vascular dysregulation, and aging, which results in increased outflow resistance and ocular hypertension. Schlemm's canal (SC) serves as th...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452417/ https://www.ncbi.nlm.nih.gov/pubmed/34552687 http://dx.doi.org/10.1155/2021/9397960 |
_version_ | 1784570061379338240 |
---|---|
author | Lou, Xiaotong Mou, Qianxue Zhao, Bowen Huang, Jingqiu Yao, Ke Luo, Zhaoxia Ye, Meng Hu, Yuanyuan Duan, Qiming Li, Xing Wen, Zheng Chen, Zhiqi Zhang, Hong Zhao, Yin |
author_facet | Lou, Xiaotong Mou, Qianxue Zhao, Bowen Huang, Jingqiu Yao, Ke Luo, Zhaoxia Ye, Meng Hu, Yuanyuan Duan, Qiming Li, Xing Wen, Zheng Chen, Zhiqi Zhang, Hong Zhao, Yin |
author_sort | Lou, Xiaotong |
collection | PubMed |
description | OBJECTIVES: In glaucomatous eyes, the main aqueous humor (AH) outflow pathway is damaged by accumulated oxidative stress arising from the microenvironment, vascular dysregulation, and aging, which results in increased outflow resistance and ocular hypertension. Schlemm's canal (SC) serves as the final filtration barrier of the main AH outflow pathway. The present study is aimed at investigating the possible regulation of vasoactive intestinal peptide (VIP) on the cytoskeleton by stabilizing ZO-1 in SC. METHODS: Model of chronic ocular hypertension (COH) induced by episcleral venous cauterization was treated with topical VIP. The ultrastructure of junctions, ZO-1 levels, and permeability of the SC inner wall to FITC-dextran (70 kDa) were detected in the COH models. The F-actin distribution, F/G-actin ratio, and ZO-1 degradation pathway in human umbilical vein endothelial cells (HUVECs) and HEK 293 cells were investigated. RESULTS: ZO-1 in the outer wall of the SC was less than that in the inner wall. COH elicited junction disruption, ZO-1 reduction, and increased permeability of the SC inner wall to FITC-dextran in rats. ZO-1 plays an essential role in maintaining the F/G-actin ratio and F-actin distribution. VIP treatment attenuated the downregulation of ZO-1 associated with COH or H(2)O(2)-induced oxidative damage. In H(2)O(2)-stimulated HUVECs, the caspase-3 inhibitor prevents ZO-1 disruption. Caspase-3 activation promoted endolysosomal degradation of ZO-1. Furthermore, a decrease in caspase-3 activation and cytoskeleton redistribution was demonstrated in VIP + H(2)O(2)-treated cells. The knockdown of ZO-1 or the overexpression of caspase-3 blocked the effect of VIP on the cytoskeleton. CONCLUSION: This study provides insights into the role of VIP in stabilizing the interaction between the actin cytoskeleton and cell junctions and may provide a promising targeted strategy for glaucoma treatment. |
format | Online Article Text |
id | pubmed-8452417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-84524172021-09-21 VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation Lou, Xiaotong Mou, Qianxue Zhao, Bowen Huang, Jingqiu Yao, Ke Luo, Zhaoxia Ye, Meng Hu, Yuanyuan Duan, Qiming Li, Xing Wen, Zheng Chen, Zhiqi Zhang, Hong Zhao, Yin Oxid Med Cell Longev Research Article OBJECTIVES: In glaucomatous eyes, the main aqueous humor (AH) outflow pathway is damaged by accumulated oxidative stress arising from the microenvironment, vascular dysregulation, and aging, which results in increased outflow resistance and ocular hypertension. Schlemm's canal (SC) serves as the final filtration barrier of the main AH outflow pathway. The present study is aimed at investigating the possible regulation of vasoactive intestinal peptide (VIP) on the cytoskeleton by stabilizing ZO-1 in SC. METHODS: Model of chronic ocular hypertension (COH) induced by episcleral venous cauterization was treated with topical VIP. The ultrastructure of junctions, ZO-1 levels, and permeability of the SC inner wall to FITC-dextran (70 kDa) were detected in the COH models. The F-actin distribution, F/G-actin ratio, and ZO-1 degradation pathway in human umbilical vein endothelial cells (HUVECs) and HEK 293 cells were investigated. RESULTS: ZO-1 in the outer wall of the SC was less than that in the inner wall. COH elicited junction disruption, ZO-1 reduction, and increased permeability of the SC inner wall to FITC-dextran in rats. ZO-1 plays an essential role in maintaining the F/G-actin ratio and F-actin distribution. VIP treatment attenuated the downregulation of ZO-1 associated with COH or H(2)O(2)-induced oxidative damage. In H(2)O(2)-stimulated HUVECs, the caspase-3 inhibitor prevents ZO-1 disruption. Caspase-3 activation promoted endolysosomal degradation of ZO-1. Furthermore, a decrease in caspase-3 activation and cytoskeleton redistribution was demonstrated in VIP + H(2)O(2)-treated cells. The knockdown of ZO-1 or the overexpression of caspase-3 blocked the effect of VIP on the cytoskeleton. CONCLUSION: This study provides insights into the role of VIP in stabilizing the interaction between the actin cytoskeleton and cell junctions and may provide a promising targeted strategy for glaucoma treatment. Hindawi 2021-09-13 /pmc/articles/PMC8452417/ /pubmed/34552687 http://dx.doi.org/10.1155/2021/9397960 Text en Copyright © 2021 Xiaotong Lou et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lou, Xiaotong Mou, Qianxue Zhao, Bowen Huang, Jingqiu Yao, Ke Luo, Zhaoxia Ye, Meng Hu, Yuanyuan Duan, Qiming Li, Xing Wen, Zheng Chen, Zhiqi Zhang, Hong Zhao, Yin VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation |
title | VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation |
title_full | VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation |
title_fullStr | VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation |
title_full_unstemmed | VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation |
title_short | VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation |
title_sort | vip stabilizes the cytoskeleton of schlemm's canal endothelia via reducing caspase-3 mediated zo-1 endolysosomal degradation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452417/ https://www.ncbi.nlm.nih.gov/pubmed/34552687 http://dx.doi.org/10.1155/2021/9397960 |
work_keys_str_mv | AT louxiaotong vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT mouqianxue vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT zhaobowen vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT huangjingqiu vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT yaoke vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT luozhaoxia vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT yemeng vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT huyuanyuan vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT duanqiming vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT lixing vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT wenzheng vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT chenzhiqi vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT zhanghong vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation AT zhaoyin vipstabilizesthecytoskeletonofschlemmscanalendotheliaviareducingcaspase3mediatedzo1endolysosomaldegradation |